A Class I HDAC Inhibitor BG45 Alleviates Cognitive Impairment through the CaMKII/ITPKA/Ca<sup>2+</sup> Signaling Pathway
Alzheimer's disease (AD) seriously endangers the health and life of elderly individuals worldwide. However, despite all scientific efforts, at the moment there are no effective clinical treatment options for AD. In this work, the effect of the class I histone deacetylase inhibitor (HDACI) BG45...
Saved in:
Main Authors: | Jingyun Liu (Author), Chenghong Zhang (Author), Jiale Wang (Author), Yufei Huang (Author), Di Shen (Author), Yingqiu Hu (Author), Haiying Chu (Author), Xuebin Yu (Author), Liyuan Zhang (Author), Haiying Ma (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CaMKII-dependent regulation of cardiac Na<sup>+</sup> homeostasis
by: Eleonora eGrandi, et al.
Published: (2014) -
Mechanisms of CaMKII Activation
by: Jeffrey R Erickson
Published: (2014) -
Enhanced Cardiac CaMKII Oxidation and CaMKII-Dependent SR Ca Leak in Patients with Sleep-Disordered Breathing
by: Michael Arzt, et al.
Published: (2022) -
CaMKII in Cardiac Health and Disease
by: Andrew G Edwards
Published: (2014) -
CaMKII regulation of cardiac K channels
by: Julian eMustroph, et al.
Published: (2014)